Immune Mechanisms in Dermatology

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 49

Special Issue Editor


E-Mail Website
Guest Editor
Chief of the First Clinic of Dermatology, Department of Dermatology, “Carol Davila” University of Medicine and Pharmacy, Colentina Hospital, 020125 Bucharest, Romania
Interests: skin cancer; dermoscopy; melanom; psoriasis; connective tissue diseases; venereology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

As the largest human organ, the skin performs multiple functions to protect the DNA of every cell. In 2024, the complex immunological mechanisms are becoming increasingly deeply understood.

Significant progress has been made in understanding and describing innate and acquired immunity, from (mostly epidermal) skin carcinogenesis to STDs. We now define melanoma as “a genetic and immunological tumor” and use direct immunological therapies in the metastatic form that were not imagined a few decades ago.

We develop local therapies based on Toll-like receptor (TLR) modulators, as these factors of innate immunity are well-understood in the signaling cascade from cutaneous viral infections (including DNA) to skin carcinomas. We correlate the presence of basal cell carcinoma with decreased immunity of the individual as we assess the signaling function of the skin.

We understand the superior acantholysis and apoptolysis in pemphigus and are more confident in the diagnosis when we corroborate histopathological examination with DIF and IIF. We treat urticaria with biologicals against IgE and psoriasis with biologicals against activated interleukins. We use PRP therapy in various conditions with promising results.

The aim of this issue of the prestigious journal Biomedicines is to publish quality research that pushes forward the field of knowledge in dermatological immunology.

Dr. Olga Simionescu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • skin innate immunity
  • skin acquired immunity
  • biologics
  • immunofluorescence
  • PRP
  • viral skin infections
  • bullous disorders
  • connective tissue disorders
  • skin cancer immunology

Published Papers

This special issue is now open for submission.
Back to TopTop